Food allergy: mechanisms and therapeutics (Q37937857)

25 August 2017

1 reference

title

Food allergy: mechanisms and therapeutics (English)

1 reference

25 August 2017

1 reference

Scott Sicherer

1 reference

25 August 2017

M. Cecilia Berin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21943957

13 December 2024

Scott Sicherer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21943957

13 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21943957

13 December 2024

publication date

21 September 2011

1 reference

full work available at URL

25 August 2017

https://api.elsevier.com/content/article/PII:S0952791511001191?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

https://api.elsevier.com/content/article/PII:S0952791511001191?httpAccept=text/plain

13 December 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Current Opinion in Immunology

13 December 2024

published in

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

794-800

1 reference

Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy.

25 August 2017

cites work

1 reference

5 October 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.JACI.2011.01.031

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Household peanut consumption as a risk factor for the development of peanut allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Development of an adjuvant-free cashew nut allergy mouse model.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Targeting Toll-like receptors on dendritic cells modifies the T(H)2 response to peanut allergens in vitro

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Peanuts can contribute to anaphylactic shock by activating complement.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Soybean isoflavones regulate dendritic cell function and suppress allergic sensitization to peanut

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Common variants at 5q22 associate with pediatric eosinophilic esophagitis

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Ara h 1-reactive T cells in individuals with peanut allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Contribution of IgE and immunoglobulin free light chain in the allergic reaction to cow's milk proteins.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Future therapies for food allergies

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Food allergy: recent advances in pathophysiology and treatment.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Mechanisms of immune tolerance relevant to food allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Clinical efficacy and immune regulation with peanut oral immunotherapy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Safety of a peanut oral immunotherapy protocol in children with peanut allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Adverse reactions during peanut oral immunotherapy home dosing

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Oral peanut immunotherapy in children with peanut anaphylaxis.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Efficacy and safety of high‐dose peanut oral immunotherapy with factors predicting outcome

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy.

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Dietary baked milk accelerates the resolution of cow's milk allergy in children

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy

13 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COI.2011.08.010

13 December 2024

Identifiers

DOI

1 reference

25 August 2017

1 reference